K2 Principal Fund’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Buy
+15,000
New +$1.05M 0.05% 292
2025
Q3
Sell
-9,100
Closed -$1.18M 367
2025
Q2
$1.18M Buy
9,100
+5,000
+122% +$725K 0.16% 140
2025
Q1
$653K Sell
4,100
-5,900
-59% -$1.07M 0.08% 180
2024
Q4
$1.85M Sell
10,000
-12,000
-55% -$2.33M 0.21% 117
2024
Q3
$4.64M Buy
22,000
+18,600
+547% +$3.23M 0.67% 55
2024
Q2
$455K Buy
+3,400
New +$643K 0.08% 148
2023
Q2
Sell
-6,000
Closed -$1.4M 256
2023
Q1
$1.4M Buy
+6,000
New +$1.52M 0.19% 109
2022
Q4
Sell
-9,000
Closed -$1.6M 283
2022
Q3
$1.6M Buy
9,000
+1,400
+18% +$281K 0.18% 109
2022
Q2
$1.39M Buy
+7,600
New +$1.52M 0.15% 135

Other funds holding INSP

K2 Principal Fund's INSP Position: Q1 2023 in Review

K2 Principal Fund sold out of Inspire Medical Systems (INSP) in Q1 2023, closing a stake of 14,956 shares — an estimated $3.78M sold.

K2 Principal Fund first reported a position in INSP in Q1 2022 and held it in 3 quarters. The position peaked at $7.93M in Q1 2022. 373 funds tracked by Wall St. Rank hold INSP as of Q1 2023.

  • K2 Principal Fund reported no remaining Inspire Medical Systems position as of Q1 2023 after selling out during the quarter.
  • K2 Principal Fund sold 14,956 Inspire Medical Systems shares in Q1 2023, an estimated $3.78M.
  • K2 Principal Fund first reported a position in Inspire Medical Systems in Q1 2022 and held it in 3 quarters.
  • K2 Principal Fund's Inspire Medical Systems position peaked at $7.93M in Q1 2022.
  • 373 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2023.

Based on K2 Principal Fund's 13F filing for Q1 2023, filed 11 May 2023.